Showing results (71-80 of 84) with videos related to
Sort By:
Pageof 9
The Journal of Antimicrobial Chemotherapy|February 9, 2012
The role of polymorphisms at position 89 in the HIV-1 protease gene in the development of drug resistance to HIV-1 protease inhibitorsJorge L Martinez-Cajas, Mark A Wainberg, Maureen Oliveira, et al.Antimicrobial Agents and Chemotherapy|October 4, 2006
High prevalence of the K65R mutation in human immunodeficiency virus type 1 subtype C isolates from infected patients in Botswana treated with didanosine-based regimensFlorence Doualla-Bell, Ava Avalos, Bluma Brenner, et al.The Journal of Antimicrobial Chemotherapy|April 1, 2016
Development of a G118R mutation in HIV-1 integrase following a switch to dolutegravir monotherapy leading to cross-resistance to integrase inhibitorsBluma G Brenner, Réjean Thomas, José Luis Blanco, et al.Antimicrobial Agents and Chemotherapy|May 23, 2012
Maraviroc and other HIV-1 entry inhibitors exhibit a class-specific redistribution effect that results in increased extracellular viral loadVictor G Kramer, Susan M Schader, Maureen Oliveira, et al.Antimicrobial Agents and Chemotherapy|July 17, 2013
Basis for early and preferential selection of the E138K mutation in HIV-1 reverse transcriptaseMatthew McCallum, Maureen Oliveira, Ruxandra-Ilinca Ibanescu, et al.Journal of Medical Virology|December 2, 2008
PL-100, a novel HIV-1 protease inhibitor displaying a high genetic barrier to resistance: an in vitro selection studySerge Dandache, Craig A Coburn, Maureen Oliveira, et al.Antiviral Chemistry & Chemotherapy|July 8, 2015
Identification of a dibenzocyclooctadiene lignan as a HIV-1 non-nucleoside reverse transcriptase inhibitorYing-Shan Han, Wei-Lie Xiao, Hongtao Xu, et al.Antimicrobial Agents and Chemotherapy|April 25, 2013
Effect of mutations at position E138 in HIV-1 reverse transcriptase and their interactions with the M184I mutation on defining patterns of resistance to nonnucleoside reverse transcriptase inhibitors rilpivirine and etravirineHong-Tao Xu, Susan P Colby-Germinario, Eugene L Asahchop, et al.Journal of Virology|January 19, 2002
Persistence and fitness of multidrug-resistant human immunodeficiency virus type 1 acquired in primary infectionBluma G Brenner, Jean-Pierre Routy, Marco Petrella, et al.Antiviral Research|June 15, 2010
Tissue culture drug resistance analysis of a novel HIV-1 protease inhibitor termed PL-100 in non-B HIV-1 subtypesEugene L Asahchop, Maureen Oliveira, Bluma G Brenner, et al.Pageof 9